AVIR

Atea Pharmaceuticals, Inc. AVIR

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$276.41M total
FMR LLC
$55.82M+0.4%
BlackRock, Inc.
$40.55M+3.4%
BML Capital Management, LLC
$32.33M-1.5%
TANG CAPITAL MANAGEMENT LLC
$22.39M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$13.79M-8.7%
Bain Capital Life Sciences Investors, LLC
$9.65M-12.1%
ACADIAN ASSET MANAGEMENT LLC
$9.46M+28.6%
GEODE CAPITAL MANAGEMENT, LLC
$9.11M+12.1%
STATE STREET CORP
$7.68M-2.5%
TWO SIGMA INVESTMENTS, LP
$7.01M-19.2%
DIMENSIONAL FUND ADVISORS LP
$6.04M+3.5%
RENAISSANCE TECHNOLOGIES LLC
$5.26M-3.0%
Rosalind Advisors, Inc.
$4.98M-8.6%
JPMORGAN CHASE & CO
$4.36M+0.6%
NORTHERN TRUST CORP
$3.51M+29.1%
MORGAN STANLEY
$3.35M-1.6%
VANGUARD PORTFOLIO MANAGEMENT LLC
$2.93M+13.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$2.84M+2.3%
GOLDMAN SACHS GROUP INC
$2.47M-9.8%
VANGUARD FIDUCIARY TRUST CO
$2.18M-3.1%
CM Management, LLC
$1.65M0.0%
BARCLAYS PLC
$1.62M+116.6%
D. E. Shaw & Co., Inc.
$1.61M-9.0%
BANQUE PICTET & CIE SA
$1.60M0.0%
MILLENNIUM MANAGEMENT LLC
$1.42M-13.0%
See all 125 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AVIR

Earnings Per Share

13fpro.ai/company/AVIR

Loading ratio trend…

AVIR key financials by period

Reported revenue, net income and operating margin by fiscal year, from Atea Pharmaceuticals, Inc.'s annual filings on SEC EDGAR.

Atea Pharmaceuticals, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2021$351.4M$121.2M39.4%
FY 2020$48.6M$-10.9M-22.7%
Source: AVIR filings on SEC EDGAR →

AVIR insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Atea Pharmaceuticals, Inc. (AVIR): stock profile, AI score and financials

Atea Pharmaceuticals, Inc. (AVIR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AVIR is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of AVIR by reported 13-F value include FMR, BlackRock, BML Capital Management, based on the most recent SEC filings. AVIR trades on the Nasdaq exchange and files with the SEC under CIK 1593899. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVIR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Atea Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1593899 →